1. Home
  2. RYTM vs EEFT Comparison

RYTM vs EEFT Comparison

Compare RYTM & EEFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RYTM
  • EEFT
  • Stock Information
  • Founded
  • RYTM 2008
  • EEFT 1994
  • Country
  • RYTM United States
  • EEFT United States
  • Employees
  • RYTM N/A
  • EEFT N/A
  • Industry
  • RYTM Biotechnology: Pharmaceutical Preparations
  • EEFT EDP Services
  • Sector
  • RYTM Health Care
  • EEFT Technology
  • Exchange
  • RYTM Nasdaq
  • EEFT Nasdaq
  • Market Cap
  • RYTM 3.8B
  • EEFT 4.1B
  • IPO Year
  • RYTM 2017
  • EEFT 1997
  • Fundamental
  • Price
  • RYTM $61.74
  • EEFT $94.70
  • Analyst Decision
  • RYTM Strong Buy
  • EEFT Buy
  • Analyst Count
  • RYTM 12
  • EEFT 7
  • Target Price
  • RYTM $74.92
  • EEFT $125.86
  • AVG Volume (30 Days)
  • RYTM 940.6K
  • EEFT 495.0K
  • Earning Date
  • RYTM 05-06-2025
  • EEFT 04-24-2025
  • Dividend Yield
  • RYTM N/A
  • EEFT N/A
  • EPS Growth
  • RYTM N/A
  • EEFT 17.26
  • EPS
  • RYTM N/A
  • EEFT 6.45
  • Revenue
  • RYTM $130,126,000.00
  • EEFT $3,989,800,000.00
  • Revenue This Year
  • RYTM $43.84
  • EEFT $9.55
  • Revenue Next Year
  • RYTM $65.62
  • EEFT $7.53
  • P/E Ratio
  • RYTM N/A
  • EEFT $14.68
  • Revenue Growth
  • RYTM 68.06
  • EEFT 8.18
  • 52 Week Low
  • RYTM $35.17
  • EEFT $85.24
  • 52 Week High
  • RYTM $68.58
  • EEFT $117.66
  • Technical
  • Relative Strength Index (RSI)
  • RYTM 61.94
  • EEFT 42.91
  • Support Level
  • RYTM $59.54
  • EEFT $92.89
  • Resistance Level
  • RYTM $62.83
  • EEFT $99.46
  • Average True Range (ATR)
  • RYTM 4.27
  • EEFT 4.91
  • MACD
  • RYTM 1.00
  • EEFT -0.63
  • Stochastic Oscillator
  • RYTM 92.04
  • EEFT 39.81

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its lead asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.

About EEFT Euronet Worldwide Inc.

Euronet Worldwide Inc is a provider of electronic financial transaction solutions. It offers payment and transaction processing and distribution solutions to financial institutions, retailers, service providers, and individual consumers. The company's product offerings include comprehensive ATM, POS, card outsourcing, card issuing and merchant acquiring services, software solutions, money transfer services, etc. Its reportable operating segments are EFT Processing, epay, and Money Transfer. Maximum revenue is derived from its Money Transfer segment, which provides money transfer services across the world under the brand names Ria, AFEX, IME, and xe. Geographically, the company generates maximum revenue from the United States, followed by Germany, India, France, Greece, and other regions.

Share on Social Networks: